变量,类型,阴性组(n=107),阳性组(n=46),P值
出血风险评估（1/0）,分类,35/107 (32.7%),46/46 (100.0%),8.033167340756614e-14
潜在可预防VTE,分类,87/107 (81.3%),15/46 (32.6%),1.4076281715711507e-08
VTE首次中高危评分日期与机械预防日期差值_none,分类,69/107 (64.5%),11/46 (23.9%),9.388123988378713e-06
首次VTE中高风险评分日期与机械预防日期差值_无,分类,69/107 (64.5%),11/46 (23.9%),9.388123988378713e-06
VTE中高危评分,连续,6.48±2.67,8.57±3.38,0.0001331873590527223
白细胞计数(*10^9/L),连续,7.90±3.71,10.27±3.81,0.0001795642836865405
机械预防措施（VTE确诊前）_0,分类,67/107 (62.6%),14/46 (30.4%),0.0005007508556371849
机械预防措施（VTE确诊前）_气压治疗,分类,40/107 (37.4%),32/46 (69.6%),0.0005007508556371849
是否机械预防,分类,40/107 (37.4%),32/46 (69.6%),0.0005007508556371849
中性粒细胞绝对值(NEUT#)（*10^9/L）,连续,5.83±3.48,7.94±3.95,0.0008731470303880177
VTE首次中高危评分日期与机械预防日期差值_0,分类,15/107 (14.0%),18/46 (39.1%),0.0011596885365428194
首次D-二聚体检测数值（μg/ml FEU）,连续,2.62±2.76,3.75±2.80,0.001872454192079802
炎症,分类,53/107 (49.5%),35/46 (76.1%),0.004123916815233382
90天前是否我院就诊,分类,68/107 (63.6%),17/46 (37.0%),0.0042600488869042295
预防措施_无预防,分类,21/107 (19.6%),1/46 (2.2%),0.010173474878281493
活化凝血酶原时间APTT,连续,29.49±5.01,27.31±3.55,0.010437079713281418
Braden量表,连续,17.54±4.41,15.37±4.84,0.010504347103357795
首次VTE中高风险评分日期与机械预防日期差值,连续,0.72±5.77,-0.63±7.59,0.011706990937254117
首次异常D-二聚体检测数值（μg/ml FEU）_0.56,分类,16/107 (15.0%),0/46 (0.0%),0.013008732372013826
VTE诊断日期与入院日期是否大于24h,分类,65/107 (60.7%),38/46 (82.6%),0.014065742556287866
预防措施_药物预防+机械预防,分类,32/107 (29.9%),24/46 (52.2%),0.014734730712170253
住院天数,连续,17.36±11.39,21.39±10.74,0.016976634351996662
本次入院前90天有无住院史、治疗史、手术史,分类,76/107 (71.0%),23/46 (50.0%),0.02081739709071462
入院科室_神经外科,分类,11/107 (10.3%),12/46 (26.1%),0.023705645111361244
VTE确诊日期与入院日期差值,连续,4.79±7.12,6.65±5.72,0.02566770288529524
感染史,分类,65/107 (60.7%),37/46 (80.4%),0.029130593945844066
血红蛋白浓度HGB【确诊前最近一次】(g/L),连续,111.96±25.48,104.02±21.94,0.036868396769679866
高血压史,分类,51/107 (47.7%),31/46 (67.4%),0.03874371688109126
是否疲惫,分类,23/107 (21.5%),18/46 (39.1%),0.03946311584656371
肾功能不全,分类,25/107 (23.4%),19/46 (41.3%),0.040049316439184426
主要疾病诊断_颈部脊髓损伤,分类,0/107 (0.0%),3/46 (6.5%),0.042142377153268795
VTE首次中高危评分日期与机械预防日期差值_-1,分类,0/107 (0.0%),3/46 (6.5%),0.042142377153268795
红细胞计数(*10^12/L),连续,3.84±0.83,3.60±0.72,0.04775473107534157
首次VTE中高风险评分日期与药物预防日期差值,连续,1.74±3.71,0.15±4.69,0.06236962843596028
首次DD与入院日期差值与VTE首次中高危评分日期差值,连续,-0.11±2.08,0.59±2.35,0.08735896650164056
是否久坐/卧床,分类,65/107 (60.7%),35/46 (76.1%),0.10034437588225381
预防措施_机械预防,分类,8/107 (7.5%),8/46 (17.4%),0.12123338173365153
是否存在抗凝禁忌,分类,66/107 (61.7%),35/46 (76.1%),0.12386100033317624
预防措施_药物预防,分类,46/107 (43.0%),13/46 (28.3%),0.1247086711539975
VTE首次中高危评分日期与药物预防日期差值_2,分类,8/107 (7.5%),0/46 (0.0%),0.1313030134596027
VTE首次中高危评分日期与药物预防日期差值_6,分类,1/107 (0.9%),3/46 (6.5%),0.15170124205295193
嗜酸性粒细胞比值,连续,2.03±2.06,1.62±1.85,0.15330285264900442
首次异常D-二聚体检测数值（μg/ml FEU）_3.71,分类,0/107 (0.0%),2/46 (4.3%),0.16301590755704218
VTE首次中高危评分日期与机械预防日期差值_-3,分类,0/107 (0.0%),2/46 (4.3%),0.16301590755704218
VTE首次中高危评分日期与药物预防日期差值_-14,分类,0/107 (0.0%),2/46 (4.3%),0.16301590755704218
VTE首次中高危评分日期与药物预防日期差值_-2,分类,0/107 (0.0%),2/46 (4.3%),0.16301590755704218
入院科室_妇科,分类,0/107 (0.0%),2/46 (4.3%),0.16301590755704218
VTE评估量表（padua1，caprini2，P+C3）_padua,分类,70/107 (65.4%),24/46 (52.2%),0.17304628339328382
性别_女,分类,51/107 (47.7%),16/46 (34.8%),0.19535789216155092
性别_男,分类,56/107 (52.3%),30/46 (65.2%),0.19535789216155092
主要疾病诊断_脑梗死恢复期,分类,10/107 (9.3%),1/46 (2.2%),0.21739946682541234
是否体力活动水平低,分类,52/107 (48.6%),28/46 (60.9%),0.22360381826969686
VTE评估量表（padua1，caprini2，P+C3）_caprini,分类,34/107 (31.8%),20/46 (43.5%),0.22840803626867323
总钙(mmol/L),连续,2.13±0.14,2.18±0.18,0.23705124485630902
入院科室_甲乳血管外科,分类,5/107 (4.7%),0/46 (0.0%),0.3197982745448426
VTE首次中高危评分日期与机械预防日期差值_2,分类,5/107 (4.7%),0/46 (0.0%),0.3197982745448426
VTE首次中高危评分日期与药物预防日期差值_9,分类,2/107 (1.9%),3/46 (6.5%),0.3229610683540187
入院科室_脊柱外科,分类,2/107 (1.9%),3/46 (6.5%),0.3229610683540187
入院科室_康复科,分类,20/107 (18.7%),5/46 (10.9%),0.3362943706316735
糖尿病史,分类,30/107 (28.0%),17/46 (37.0%),0.3652087240802996
VTE首次中高危评分日期与机械预防日期差值_1,分类,4/107 (3.7%),4/46 (8.7%),0.38589647322901577
入院舒张压,连续,79.36±12.69,77.07±14.70,0.39427029933758606
VTE首次中高危评分日期与药物预防日期差值_7,分类,4/107 (3.7%),0/46 (0.0%),0.43753952216565306
VTE首次中高危评分日期与药物预防日期差值_8,分类,4/107 (3.7%),0/46 (0.0%),0.43753952216565306
入院科室_重症医学科,分类,4/107 (3.7%),0/46 (0.0%),0.43753952216565306
VTE首次中高危评分日期与机械预防日期差值_3,分类,4/107 (3.7%),0/46 (0.0%),0.43753952216565306
主要疾病诊断_颅内动脉瘤破裂伴蛛网膜下腔出血,分类,1/107 (0.9%),2/46 (4.3%),0.44696567839788104
入院科室_骨关节科,分类,1/107 (0.9%),2/46 (4.3%),0.44696567839788104
主要疾病诊断_脑内出血,分类,1/107 (0.9%),2/46 (4.3%),0.44696567839788104
主要疾病诊断_肺部感染,分类,1/107 (0.9%),2/46 (4.3%),0.44696567839788104
呼吸系统疾病/COPD,分类,52/107 (48.6%),26/46 (56.5%),0.46988827856177506
纤维蛋白原Fbg（g/L）,连续,3.70±1.32,4.02±1.61,0.47507238029659704
凝血酶原时间PT（s）,连续,12.36±1.63,12.44±1.42,0.478510790619324
RBC平均血红蛋白量(MCH),连续,29.50±2.94,29.32±2.59,0.49617580362527547
钾离子,连续,3.90±0.49,3.95±0.53,0.5000208177613358
VTE首次中高危评分日期与药物预防日期差值_none,分类,30/107 (28.0%),10/46 (21.7%),0.5403128782079616
是否药物预防,分类,80/107 (74.8%),37/46 (80.4%),0.5822385269283299
VTE首次中高危评分日期与药物预防日期差值_0,分类,20/107 (18.7%),11/46 (23.9%),0.6048229685299278
首次DD与入院日期差值,分类,50/107 (46.7%),30/46 (65.2%),0.6071247574788033
入院科室_血液科,分类,3/107 (2.8%),0/46 (0.0%),0.6092498139256624
首次异常D-二聚体检测数值（μg/ml FEU）_1.21,分类,3/107 (2.8%),0/46 (0.0%),0.6092498139256624
主要疾病诊断_急性脑梗死,分类,3/107 (2.8%),0/46 (0.0%),0.6092498139256624
主要疾病诊断_慢性肾脏病5期,分类,3/107 (2.8%),0/46 (0.0%),0.6092498139256624
入院科室_感染科,分类,3/107 (2.8%),0/46 (0.0%),0.6092498139256624
首次异常D-二聚体检测数值（μg/ml FEU）_1.12,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_0.99,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_多处受压区压疮 IV期,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_左股骨颈骨折,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_慢性阻塞性肺病伴有急性下呼吸道感染,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_急性脑梗死 ,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_恶性肿瘤靶向治疗,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_感染性休克,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_左侧基底节脑出血,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_头晕查因：后循环缺血？,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_1.28,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_细菌性肺炎,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_大脑前-前交通动脉瘤破裂伴蛛网膜下腔出血,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_1.71,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_右侧颞叶出血,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_左额叶、胼胝体膝部脑出血,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_急性上消化道出血：消化性溃疡并出血,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_1.37,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_1.42,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_1.66,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_大脑动脉闭塞脑梗死,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_大脑中动脉瘤破裂伴蛛网膜下隙出血,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_右膝半月板损伤,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_左侧附件区转移性鳞癌,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_右侧丘脑出血,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_发热、呕吐,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_左侧多发肋骨骨折（4-8肋）,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
入院科室_内分泌科,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
VTE首次中高危评分日期与药物预防日期差值_-5,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
入院科室_心胸外科,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_左肺腺癌Ⅲ期,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_手术后恶性肿瘤化学治疗第三次化疗后,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
VTE首次中高危评分日期与机械预防日期差值_-33,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
VTE首次中高危评分日期与药物预防日期差值_-27,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
VTE首次中高危评分日期与药物预防日期差值_-11,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_腰椎间盘突出,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_胸椎脱位t11/t12,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_0.66,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_脑干出血,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_0.65,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
VTE首次中高危评分日期与机械预防日期差值_-7,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
VTE首次中高危评分日期与机械预防日期差值_-14,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
VTE首次中高危评分日期与机械预防日期差值_-8,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
VTE首次中高危评分日期与机械预防日期差值_12,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_6.6,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_6.55,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_5.3,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_6.4,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_4.91,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_4.76,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_3.66,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_5.01,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_3.4,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_3.24,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_2.95,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_2.67,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_23.42,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_14.19,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_9.23,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_3.53,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_4.16,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_3.8,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
VTE首次中高危评分日期与药物预防日期差值_17,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_4.67,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_2.1,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_2.16,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_右侧基底节区脑出血,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_1.83,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_25.39,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_29.74,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_2型糖尿病,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_便血,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_7.32,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
主要疾病诊断_全身多发损伤,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_2.37,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_2.52,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_8.39,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_4.2,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_3.81,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_9.14,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
首次异常D-二聚体检测数值（μg/ml FEU）_4.56,分类,0/107 (0.0%),1/46 (2.2%),0.6627154581294237
嗜酸粒细胞绝对值(E0#)（*10^9/L）,连续,0.14±0.15,0.15±0.18,0.6712636608050759
入院收缩压,连续,130.47±21.03,133.74±26.67,0.7009470099508198
是否步速缓慢,分类,46/107 (43.0%),22/46 (47.8%),0.7080120249424393
出院舒张压,连续,75.49±10.67,75.59±12.92,0.7364928281348108
入院科室_肿瘤科,分类,4/107 (3.7%),3/46 (6.5%),0.7386357355103059
主要疾病诊断_重症肺炎,分类,2/107 (1.9%),2/46 (4.3%),0.7424605542082268
VTE首次中高危评分日期与药物预防日期差值_4,分类,2/107 (1.9%),2/46 (4.3%),0.7424605542082268
手术史,分类,58/107 (54.2%),23/46 (50.0%),0.7631976252681414
RBC平均血红蛋白浓度(MCHC),连续,328.79±13.47,328.67±14.64,0.7789813441549854
入院科室_肾内科,分类,5/107 (4.7%),1/46 (2.2%),0.7825068220658675
VTE首次中高危评分日期与入院日期差值,分类,34/107 (31.8%),22/46 (47.8%),0.805779552906468
入院科室_呼吸与危重症医学科,分类,11/107 (10.3%),6/46 (13.0%),0.8272955118301599
身高,连续,1.62±0.08,1.63±0.08,0.8479406208694038
首次异常DD与入院日期差值,分类,76/107 (71.0%),35/46 (76.1%),0.8562913281430866
入院科室_创伤骨科,分类,2/107 (1.9%),0/46 (0.0%),0.8750442619737022
VTE首次中高危评分日期与药物预防日期差值_-3,分类,2/107 (1.9%),0/46 (0.0%),0.8750442619737022
VTE首次中高危评分日期与药物预防日期差值_10,分类,2/107 (1.9%),0/46 (0.0%),0.8750442619737022
VTE首次中高危评分日期与机械预防日期差值_9,分类,2/107 (1.9%),0/46 (0.0%),0.8750442619737022
入院科室_风湿免疫科,分类,2/107 (1.9%),0/46 (0.0%),0.8750442619737022
VTE首次中高危评分日期与药物预防日期差值_5,分类,2/107 (1.9%),0/46 (0.0%),0.8750442619737022
首次异常D-二聚体检测数值（μg/ml FEU）_4.38,分类,2/107 (1.9%),0/46 (0.0%),0.8750442619737022
首次异常D-二聚体检测数值（μg/ml FEU）_1.65,分类,2/107 (1.9%),0/46 (0.0%),0.8750442619737022
首次异常D-二聚体检测数值（μg/ml FEU）_1.2,分类,2/107 (1.9%),0/46 (0.0%),0.8750442619737022
VTE首次中高危评分日期与药物预防日期差值_13,分类,2/107 (1.9%),0/46 (0.0%),0.8750442619737022
主要疾病诊断_下肢深静脉血栓形成,分类,2/107 (1.9%),0/46 (0.0%),0.8750442619737022
入院科室_普外科,分类,7/107 (6.5%),2/46 (4.3%),0.877396434960782
BMI,连续,22.58±2.84,23.00±3.36,0.9315930126118499
年龄,连续,63.20±15.46,63.50±13.95,0.9904720687981372
入院科室_心血管内科,分类,4/107 (3.7%),1/46 (2.2%),0.9974143582208179
VTE首次中高危评分日期与药物预防日期差值_37,分类,1/107 (0.9%),0/46 (0.0%),1.0
VTE首次中高危评分日期与药物预防日期差值_19,分类,1/107 (0.9%),0/46 (0.0%),1.0
VTE首次中高危评分日期与药物预防日期差值_16,分类,1/107 (0.9%),0/46 (0.0%),1.0
VTE首次中高危评分日期与药物预防日期差值_15,分类,1/107 (0.9%),0/46 (0.0%),1.0
VTE首次中高危评分日期与药物预防日期差值_12,分类,1/107 (0.9%),0/46 (0.0%),1.0
VTE首次中高危评分日期与药物预防日期差值_11,分类,1/107 (0.9%),0/46 (0.0%),1.0
出院收缩压,连续,127.56±18.24,127.24±18.78,1.0
首次异常D-二聚体检测数值（μg/ml FEU）_4.75,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_4.72,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_4.63,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_4.58,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_4.27,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_3.77,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_3.76,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_3.75,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_7.17,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_7.03,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_6.59,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_6.18,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_5.85,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_5.84,分类,1/107 (0.9%),1/46 (2.2%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_5.74,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_4.92,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_4.9,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_3.67,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_3.65,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_3.28,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_3.25,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_3.21,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_3.03,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_3.0,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_2.92,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_2.69,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_2.56,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_22.0,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_21.7,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_18.12,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_14.52,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_13.67,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_12.13,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_11.33,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_7.62,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_7.44,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_7.26,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_充血性心力衰竭,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_乳腺恶性肿瘤,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_乙状结肠肿瘤,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_丙型肝炎后肝硬化失代偿期,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_丘脑出血,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_下肢静脉血栓形成,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_下肢肌肉损伤,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_1.双侧乳腺肿物性质待查：纤维腺瘤？乳腺腺病？乳腺癌？,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_50.54,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_24.08,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_2.51,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_2.49,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_2.47,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_2.33,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_2.29,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_2.27,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_2.23,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_2.01,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.94,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.85,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.81,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_取除下腔静脉滤器,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_发热查因：重症肺炎？其他？,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_双肾多发错构瘤,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_双肺肺炎（肺炎克雷伯杆菌+白色念珠菌+克柔念珠菌）,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_双侧颈内动脉C5段动脉瘤可能,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_双侧腹股沟复发性直疝,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_十二指肠腺癌并出血,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_化疗后骨髓抑制,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_前列腺恶性肿瘤并多发骨转移,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_出血性脑梗死,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_冠状动脉粥样硬化性心脏病 三支病变,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_冠状动脉粥样硬化性心脏病,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_再生障碍性贫血,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_大面积肺栓塞（高危组 ）,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_大脑中动脉狭窄,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_大气道狭窄,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_呼吸困难,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_吞咽困难,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_右髂骨粉碎性骨折,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_右胫骨骨折 ,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_右肺肺炎,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_右肺嗜肺军团菌肺炎,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_右侧胫骨髁间棘骨折,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.75,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.72,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.62,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.59,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.58,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.51,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.46,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.43,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.4,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.35,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.34,分类,1/107 (0.9%),1/46 (2.2%),1.0
主要疾病诊断_急性多发脑梗死,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_心源性脑栓塞,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_左腋神经损伤,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_左胫骨平台骨折,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_左股骨粗隆下骨折术后,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_左侧椎动脉V4段夹层动脉瘤,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_左侧大隐静脉曲张,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_左侧基底节区出血,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_慢性阻塞性肺病伴有急性加重,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_慢性肺源性心脏病失代偿期,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_恶性肿瘤维持性化学治疗,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_急性脑梗死(左侧额顶枕叶、左侧侧脑室旁、右侧额叶 心源性栓塞型可能性大),分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_急性肺栓塞,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_急性肺动脉栓塞,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_急性疼痛,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_急性心力衰竭,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_急性广泛前壁心肌梗死,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_急性大面积脑梗死,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.3,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.27,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.26,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.08,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.04,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_0.84,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_0.83,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_0.82,分类,1/107 (0.9%),1/46 (2.2%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_0.8,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_0.79,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_0.74,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_肺炎,分类,1/107 (0.9%),1/46 (2.2%),1.0
主要疾病诊断_肺栓塞,分类,1/107 (0.9%),1/46 (2.2%),1.0
主要疾病诊断_肺挫伤,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_肝脏转移瘤,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_类风湿性关节炎,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_社区获得性肺炎，重症,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_社区获得性肺炎,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_特鲁索综合征,分类,1/107 (0.9%),0/46 (0.0%),1.0
"主要疾病诊断_横结肠低分化腺癌TxNxM1,Ⅳ期",分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_梗阻性黄疸,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_支气管或肺恶性肿瘤,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_抗合成酶综合征,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_手术后恶性肿瘤化学治疗,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_腰椎压缩性骨折,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_脓毒血症,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_脑转移瘤术后恢复期,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_脑血管狭窄,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_脑血管意外,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_脑梗死,分类,3/107 (2.8%),1/46 (2.2%),1.0
主要疾病诊断_脑出血恢复期,分类,3/107 (2.8%),2/46 (4.3%),1.0
主要疾病诊断_胸痛,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_胸段脊髓胶质瘤，WHO2级,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_胆总管结石,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_胆囊结石伴急性胆囊炎,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_胃多发溃疡并出血,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_0.73,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_0.72,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_0.71,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_0.69,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_0.62,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_0.6,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_0.59,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_0.55,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_0.51,分类,1/107 (0.9%),0/46 (0.0%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_0.16,分类,1/107 (0.9%),0/46 (0.0%),1.0
VTE首次中高危评分日期与药物预防日期差值_-6,分类,1/107 (0.9%),1/46 (2.2%),1.0
VTE首次中高危评分日期与药物预防日期差值_-9,分类,1/107 (0.9%),0/46 (0.0%),1.0
VTE首次中高危评分日期与药物预防日期差值_-29,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_颅占位性病变,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_非创伤性脑内血肿,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_降结肠恶性肿瘤结肠癌伴出血,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_重型原发性免疫性血小板减少症,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_败血症,分类,1/107 (0.9%),0/46 (0.0%),1.0
主要疾病诊断_腰椎间盘突出伴神经根病,分类,1/107 (0.9%),0/46 (0.0%),1.0
VTE首次中高危评分日期与机械预防日期差值_37,分类,1/107 (0.9%),0/46 (0.0%),1.0
VTE首次中高危评分日期与机械预防日期差值_32,分类,1/107 (0.9%),1/46 (2.2%),1.0
VTE首次中高危评分日期与机械预防日期差值_8,分类,1/107 (0.9%),0/46 (0.0%),1.0
VTE首次中高危评分日期与机械预防日期差值_-2,分类,1/107 (0.9%),1/46 (2.2%),1.0
VTE首次中高危评分日期与机械预防日期差值_-4,分类,2/107 (1.9%),1/46 (2.2%),1.0
VTE首次中高危评分日期与机械预防日期差值_-5,分类,1/107 (0.9%),0/46 (0.0%),1.0
VTE首次中高危评分日期与机械预防日期差值_-29,分类,1/107 (0.9%),0/46 (0.0%),1.0
入院科室_老年医学科,分类,3/107 (2.8%),1/46 (2.2%),1.0
入院科室_神经内科,分类,12/107 (11.2%),5/46 (10.9%),1.0
入院科室_甲乳外科,分类,1/107 (0.9%),0/46 (0.0%),1.0
入院科室_消化内科,分类,3/107 (2.8%),1/46 (2.2%),1.0
VTE首次中高危评分日期与药物预防日期差值_3,分类,6/107 (5.6%),2/46 (4.3%),1.0
VTE首次中高危评分日期与药物预防日期差值_1,分类,9/107 (8.4%),4/46 (8.7%),1.0
VTE首次中高危评分日期与药物预防日期差值_-1,分类,3/107 (2.8%),2/46 (4.3%),1.0
VTE首次中高危评分日期与药物预防日期差值_-4,分类,1/107 (0.9%),0/46 (0.0%),1.0
入院科室_泌尿外科,分类,1/107 (0.9%),0/46 (0.0%),1.0
入院科室_创伤中心,分类,1/107 (0.9%),0/46 (0.0%),1.0
入院科室_全科医学科,分类,1/107 (0.9%),0/46 (0.0%),1.0
入院科室_介入科,分类,1/107 (0.9%),0/46 (0.0%),1.0
VTE评估量表（padua1，caprini2，P+C3）_padua、caprini,分类,3/107 (2.8%),2/46 (4.3%),1.0
